Release date: 17 November 2022
Promoter – Financial Intermediary
LVPHARM SALocation
Description
The project consists in launching by local private entrepreneurs the assembly, validation, and implementation of IPM' Technologies' modular plants for the pharmaceutical industry and plug-and-play biotech laboratories. The project supports small and medium sized businesses in Africa to implement turn-key modular manufacturing solutions for high-demand medicinal products.
Objectives
The aim is to generate significant positive knowledge and technology externalities, and skills development, notably in the area of the strengthening and localising pharmaceutical supply chains. This provides independent supply security for essential medicines.
Sector(s)
Proposed EIB finance (Approximate amount)
not disclosed
Total cost (Approximate amount)
not disclosed
Environmental aspects
The borrower and final beneficiaries should take all required measures to ensure that the procedures for the sub-projects comply with national legislation and the ElB's Environmental and Social Standards, as well as international treaties and conventions signed and ratified by or otherwise applicable and binding in the country.
Procurement
The borrower and final beneficiaries should take all required measures to ensure that any procurement procedure for the related sub-projects comply with the EIB's Guide to Procurement.
Status
Under appraisal - 4/10/2022
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).